NexgenRx (NXG) Stock Chart & Stock Price History C$0.28 -0.01 (-1.79%) (As of 10/22/2024) Add Compare Share Share Chart Stock AnalysisChartEarningsInsider Trades NexgenRx Stock Price Performance5 Day Performance0.00%1 Month Performance+1.85%3 Month Performance+10.00%6 Month Performance+25.00%Year-To-Date Performance+25.00%1 Year Performance+5.77% Receive NXG Stock News and Ratings via Email Sign-up to receive the latest news and ratings for NexgenRx and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Brownstone ResearchBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of my favorite stocks. Shares have jumped by more than 20,000% since then.I believe we are about to do it again with this new AI project called Stargate NXG Stock Chart for Tuesday, November, 5, 2024 NXG Chart by TradingView NexgenRx Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization11/04/2024C$0.28C$0.28C$0.28C$0.28500 shsC$19.50 million11/01/2024C$0.28C$0.28C$0.28C$0.28500 shsC$19.50 million10/31/2024C$0.28C$0.28C$0.28C$0.28500 shsC$19.50 million10/30/2024C$0.28C$0.28C$0.28C$0.28500 shsC$19.50 million10/29/2024C$0.28C$0.28C$0.28C$0.28500 shsC$19.50 million10/28/2024C$0.28C$0.28C$0.28C$0.28500 shsC$19.50 million Get the Latest News and Ratings for NXG and Related StocksEnter your email address below to receive the latest news and analysts' ratings for NexgenRx and its competitors with MarketBeat's FREE daily newsletter. 10/25/2024C$0.28C$0.28C$0.28C$0.28500 shsC$19.50 million10/24/2024C$0.28C$0.28C$0.28C$0.28500 shsC$19.50 million10/23/2024C$0.28C$0.28C$0.28C$0.28500 shsC$19.50 million10/22/2024C$0.28C$0.28-1.79%C$0.28C$0.28500 shsC$19.50 million10/21/2024C$0.28C$0.28C$0.28C$0.2810,000 shsC$19.86 million10/18/2024C$0.28C$0.28C$0.28C$0.2810,000 shsC$19.86 million10/17/2024C$0.28C$0.28C$0.28C$0.286,000 shsC$19.86 million10/16/2024C$0.28C$0.28C$0.28C$0.286,000 shsC$19.86 million10/15/2024C$0.28C$0.28C$0.28C$0.2726,000 shsC$19.86 million10/14/2024C$0.28C$0.28C$0.28C$0.2726,000 shsC$19.86 million10/11/2024C$0.28C$0.28C$0.28C$0.2726,000 shsC$19.86 million10/10/2024C$0.28C$0.28C$0.28C$0.2726,000 shsC$19.86 million10/09/2024C$0.27C$0.28+5.66%C$0.28C$0.2726,000 shsC$19.86 million10/08/2024C$0.27C$0.27C$0.27C$0.2725,000 shsC$18.79 million10/07/2024C$0.27C$0.27-1.85%C$0.27C$0.2725,000 shsC$18.79 million10/04/2024C$0.24C$0.27+12.50%C$0.27C$0.2736,500 shsC$19.15 million10/03/2024C$0.24C$0.24C$0.27C$0.24236,500 shsC$17.02 million10/02/2024C$0.24C$0.24C$0.27C$0.24236,500 shsC$17.02 million10/01/2024C$0.26C$0.24-5.88%C$0.26C$0.2433,000 shsC$17.02 million09/30/2024C$0.25C$0.26+4.08%C$0.28C$0.258,892 shsC$18.09 million09/27/2024C$0.25C$0.25C$0.25C$0.251,000 shsC$17.38 million09/26/2024C$0.25C$0.25C$0.25C$0.251,000 shsC$17.38 million09/25/2024C$0.25C$0.25C$0.25C$0.251,000 shsC$17.38 million09/24/2024C$0.26C$0.25-3.92%C$0.25C$0.251,000 shsC$17.38 million09/23/2024C$0.26C$0.26C$0.27C$0.2613,000 shsC$18.09 million09/20/2024C$0.26C$0.26C$0.27C$0.2613,000 shsC$18.09 million09/19/2024C$0.25C$0.26+2.00%C$0.27C$0.2613,000 shsC$18.09 million09/18/2024C$0.25C$0.25C$0.26C$0.2549,500 shsC$17.73 million09/17/2024C$0.25C$0.25C$0.26C$0.2549,500 shsC$17.73 million09/16/2024C$0.25C$0.25C$0.25C$0.2515,000 shsC$17.73 million09/13/2024C$0.25C$0.25C$0.25C$0.2515,000 shsC$17.73 million09/12/2024C$0.25C$0.25C$0.26C$0.2521,500 shsC$17.73 million09/11/2024C$0.25C$0.25C$0.26C$0.2521,500 shsC$17.73 million09/10/2024C$0.26C$0.25-1.96%C$0.25C$0.2534,500 shsC$17.73 millionCharles Payne Wants You Prepared for Q4 (Ad)Charles Payne Wants You Prepared for Q4 Because as we look toward 2025, there's no denying that market volatility, inflation, and recession fears are top of mind for every investor Now more than ever, it's crucial to have a solid plan for navigating uncertainty and coming out ahead. Click here to secure your seat now.09/09/2024C$0.26C$0.26C$0.29C$0.2620,250 shsC$18.09 million09/06/2024C$0.26C$0.26-1.92%C$0.29C$0.2620,250 shsC$18.09 million09/05/2024C$0.26C$0.26C$0.26C$0.265,500 shsC$18.44 million09/04/2024C$0.26C$0.26C$0.26C$0.265,500 shsC$18.44 million09/03/2024C$0.26C$0.26C$0.26C$0.265,500 shsC$18.44 million09/02/2024C$0.26C$0.26C$0.26C$0.265,500 shsC$18.44 million08/30/2024C$0.26C$0.26C$0.26C$0.265,500 shsC$18.44 million08/29/2024C$0.26C$0.26C$0.26C$0.265,500 shsC$18.44 million08/28/2024C$0.26C$0.26C$0.26C$0.265,500 shsC$18.44 million08/27/2024C$0.26C$0.26C$0.26C$0.265,500 shsC$18.44 million08/26/2024C$0.26C$0.26C$0.26C$0.2616,000 shsC$18.44 million08/23/2024C$0.24C$0.26+8.33%C$0.26C$0.2616,000 shsC$18.44 million08/22/2024C$0.25C$0.24-2.04%C$0.25C$0.2459,000 shsC$17.02 million08/21/2024C$0.25C$0.25C$0.25C$0.25500 shsC$17.38 million08/20/2024C$0.26C$0.25-5.77%C$0.25C$0.25500 shsC$17.38 million08/19/2024C$0.26C$0.26C$0.26C$0.265,000 shsC$18.44 million08/16/2024C$0.26C$0.26C$0.26C$0.265,000 shsC$18.44 million08/15/2024C$0.25C$0.26+4.00%C$0.26C$0.265,000 shsC$18.44 million08/14/2024C$0.25C$0.25C$0.26C$0.2530,000 shsC$17.73 million08/13/2024C$0.25C$0.25C$0.26C$0.2573,501 shsC$17.73 million08/12/2024C$0.25C$0.25C$0.26C$0.2573,501 shsC$17.73 million08/09/2024C$0.25C$0.25C$0.26C$0.2573,501 shsC$17.73 million08/08/2024C$0.25C$0.25C$0.26C$0.2573,501 shsC$17.73 million08/07/2024C$0.25C$0.25C$0.26C$0.2573,501 shsC$17.73 million08/06/2024C$0.25C$0.25C$0.27C$0.2532,000 shsC$17.73 million08/05/2024C$0.25C$0.25C$0.27C$0.2532,000 shsC$17.73 million Related Companies TH Stock Chart MDP Stock Chart TLT Stock Chart SUGR Stock Chart HBP Stock Chart MBX Stock Chart BCT Stock Chart KDA Stock Chart CWEB Stock Chart ASG Stock Chart Receive NXG Stock News and Ratings via EmailSign-up to receive the latest news and ratings for NexgenRx and its competitors with MarketBeat's FREE daily newsletter. This page (CVE:NXG) was last updated on 11/5/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredMissed Out On Nvidia?Artificial Intelligence is a tool with the potential to create massive distributions of wealth… In fact, it...Unstoppable Prosperity | Sponsored626 winning trades out of 647…Imagine turning nearly every Friday into a payday. That's exactly what one reclusive multi-millionaire trad...Investing Daily | Sponsored625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredWARNING: “Buffett Indicator” flashing for first time in 50 yearsWarren Buffett has sold a staggering $97 billion worth of stocks this year... But why? Our research indi...Behind the Markets | SponsoredCrypto Crash Ahead? (27 Experts Weigh In)Your Portfolio Could Be at RISK Emergency summit reveals crypto could save you!Crypto 101 Media | SponsoredNvidia is Pivoting to Solve Big Tech’s $1 Trillion ProblemTaiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as ...Weiss Ratings | SponsoredHe made 1,303,329 in 12 months after Biden won…Tim Sykes - the world’s most apolitical Millionaire trader - just sat down for an urgent election interview… ...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NexgenRx Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share NexgenRx With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
